

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 5.36535795 |
| 2 | actin-myosin filament sliding (GO:0033275) | 5.36535795 |
| 3 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.16945577 |
| 4 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.83156729 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.75572893 |
| 6 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.73575806 |
| 7 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.73481716 |
| 8 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.51184585 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.49598880 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.48850309 |
| 11 | cell communication by electrical coupling (GO:0010644) | 4.48074501 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 4.43678508 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.43385260 |
| 14 | cardiac myofibril assembly (GO:0055003) | 4.39258687 |
| 15 | vocalization behavior (GO:0071625) | 4.37358469 |
| 16 | actin-mediated cell contraction (GO:0070252) | 4.36919872 |
| 17 | heart contraction (GO:0060047) | 4.36214143 |
| 18 | heart process (GO:0003015) | 4.36214143 |
| 19 | muscle hypertrophy (GO:0014896) | 4.34425097 |
| 20 | locomotory exploration behavior (GO:0035641) | 4.32815946 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.29014280 |
| 22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.27495948 |
| 23 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.26033868 |
| 24 | muscle tissue morphogenesis (GO:0060415) | 4.22691750 |
| 25 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.16398147 |
| 26 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.14326500 |
| 27 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.13975347 |
| 28 | regulation of heart rate (GO:0002027) | 4.13092025 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.12637343 |
| 30 | cell communication involved in cardiac conduction (GO:0086065) | 4.09879684 |
| 31 | sarcomere organization (GO:0045214) | 4.05364727 |
| 32 | regulation of cardioblast differentiation (GO:0051890) | 3.99712657 |
| 33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.97336224 |
| 34 | cardiac chamber formation (GO:0003207) | 3.95653846 |
| 35 | regulation of membrane repolarization (GO:0060306) | 3.93932844 |
| 36 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.92947250 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 3.92763729 |
| 38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.92050261 |
| 39 | cardiac muscle contraction (GO:0060048) | 3.90669274 |
| 40 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.86166294 |
| 41 | muscle hypertrophy in response to stress (GO:0003299) | 3.86166294 |
| 42 | cardiac muscle adaptation (GO:0014887) | 3.86166294 |
| 43 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.84480871 |
| 44 | plasma membrane repair (GO:0001778) | 3.82606571 |
| 45 | regulation of heart contraction (GO:0008016) | 3.80235942 |
| 46 | positive regulation of action potential (GO:0045760) | 3.76021270 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.74489874 |
| 48 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73947016 |
| 49 | cardiac ventricle formation (GO:0003211) | 3.70496253 |
| 50 | cardiac cell development (GO:0055006) | 3.68362492 |
| 51 | cellular response to epinephrine stimulus (GO:0071872) | 3.65934480 |
| 52 | glutamate secretion (GO:0014047) | 3.65224885 |
| 53 | myofibril assembly (GO:0030239) | 3.64498371 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 3.59332196 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.57817328 |
| 56 | detection of calcium ion (GO:0005513) | 3.55651125 |
| 57 | regulation of ATP catabolic process (GO:1903289) | 3.52249095 |
| 58 | regulation of ATPase activity (GO:0043462) | 3.52249095 |
| 59 | activation of protein kinase A activity (GO:0034199) | 3.50959251 |
| 60 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.49915746 |
| 61 | regulation of cell communication by electrical coupling (GO:0010649) | 3.47685739 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.46341510 |
| 63 | regulation of actin filament-based movement (GO:1903115) | 3.43945601 |
| 64 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.42773730 |
| 65 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.39697793 |
| 66 | sodium ion export (GO:0071436) | 3.39410716 |
| 67 | protein localization to synapse (GO:0035418) | 3.37861721 |
| 68 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.35653244 |
| 69 | dendritic spine morphogenesis (GO:0060997) | 3.34361555 |
| 70 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.34129201 |
| 71 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.34129201 |
| 72 | neurotransmitter secretion (GO:0007269) | 3.32317199 |
| 73 | response to epinephrine (GO:0071871) | 3.31094845 |
| 74 | actin filament-based movement (GO:0030048) | 3.30784013 |
| 75 | adrenergic receptor signaling pathway (GO:0071875) | 3.25729443 |
| 76 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.24695248 |
| 77 | cardiac conduction (GO:0061337) | 3.22934816 |
| 78 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.22395811 |
| 79 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.22049517 |
| 80 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.21971018 |
| 81 | exploration behavior (GO:0035640) | 3.21605692 |
| 82 | neuronal action potential propagation (GO:0019227) | 3.20243331 |
| 83 | regulation of synaptic vesicle transport (GO:1902803) | 3.19518277 |
| 84 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.19500796 |
| 85 | cellular potassium ion homeostasis (GO:0030007) | 3.18264098 |
| 86 | positive regulation of ATPase activity (GO:0032781) | 3.17574793 |
| 87 | positive regulation of ATP catabolic process (GO:1903291) | 3.17574793 |
| 88 | potassium ion import (GO:0010107) | 3.16446471 |
| 89 | positive regulation of heart rate (GO:0010460) | 3.16002172 |
| 90 | membrane depolarization during action potential (GO:0086010) | 3.15801582 |
| 91 | regulation of relaxation of muscle (GO:1901077) | 3.15497757 |
| 92 | positive regulation of sodium ion transport (GO:0010765) | 3.13402779 |
| 93 | cellular response to catecholamine stimulus (GO:0071870) | 3.13169091 |
| 94 | cellular response to monoamine stimulus (GO:0071868) | 3.13169091 |
| 95 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.11375357 |
| 96 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11036910 |
| 97 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.08685173 |
| 98 | relaxation of cardiac muscle (GO:0055119) | 3.07871770 |
| 99 | neuron cell-cell adhesion (GO:0007158) | 3.07857428 |
| 100 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06330180 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05499521 |
| 102 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.02301439 |
| 103 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.02293661 |
| 104 | cardiac muscle hypertrophy (GO:0003300) | 2.97882652 |
| 105 | long-term memory (GO:0007616) | 2.97624317 |
| 106 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.96432054 |
| 107 | cardiac muscle cell action potential (GO:0086001) | 2.96202142 |
| 108 | adult heart development (GO:0007512) | 2.95819270 |
| 109 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.95769940 |
| 110 | potassium ion export (GO:0071435) | 2.95582015 |
| 111 | regulation of the force of heart contraction (GO:0002026) | 2.95395206 |
| 112 | membrane repolarization (GO:0086009) | 2.92789684 |
| 113 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.92365551 |
| 114 | striated muscle contraction (GO:0006941) | 2.90544920 |
| 115 | regulation of striated muscle contraction (GO:0006942) | 2.90160201 |
| 116 | glutamate receptor signaling pathway (GO:0007215) | 2.90066173 |
| 117 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.89667743 |
| 118 | synaptic transmission, glutamatergic (GO:0035249) | 2.89554039 |
| 119 | positive regulation of heart contraction (GO:0045823) | 2.87561015 |
| 120 | striatum development (GO:0021756) | 2.86839429 |
| 121 | response to catecholamine (GO:0071869) | 2.86315600 |
| 122 | response to monoamine (GO:0071867) | 2.86315600 |
| 123 | positive regulation of potassium ion transport (GO:0043268) | 2.86286691 |
| 124 | multicellular organismal signaling (GO:0035637) | 2.86037717 |
| 125 | cardiac muscle cell development (GO:0055013) | 2.85906136 |
| 126 | striated muscle hypertrophy (GO:0014897) | 2.85370838 |
| 127 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.85068152 |
| 128 | response to inactivity (GO:0014854) | 2.84561221 |
| 129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84482356 |
| 130 | auditory behavior (GO:0031223) | 2.83069401 |
| 131 | regulation of cation channel activity (GO:2001257) | 2.82956351 |
| 132 | positive regulation of cation channel activity (GO:2001259) | 2.82527560 |
| 133 | neuronal ion channel clustering (GO:0045161) | 2.82292624 |
| 134 | negative regulation of potassium ion transport (GO:0043267) | 2.82180908 |
| 135 | gamma-aminobutyric acid transport (GO:0015812) | 2.82155502 |
| 136 | muscle contraction (GO:0006936) | 2.81888738 |
| 137 | regulation of cardiac muscle contraction (GO:0055117) | 2.81072595 |
| 138 | neuron-neuron synaptic transmission (GO:0007270) | 2.80950413 |
| 139 | regulation of muscle contraction (GO:0006937) | 2.80522415 |
| 140 | actomyosin structure organization (GO:0031032) | 2.80114797 |
| 141 | neuron recognition (GO:0008038) | 2.78577386 |
| 142 | positive regulation of synapse maturation (GO:0090129) | 2.77852531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70868697 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00311585 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90252392 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79146114 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71551089 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68134028 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68134028 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59788395 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53292224 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49733616 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48102522 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48003594 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45059229 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37517319 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33681360 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29216906 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28348340 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26907375 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20471659 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10639700 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10537269 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10219801 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02653943 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.97441127 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.95190997 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.88772205 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.81368724 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80059050 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56453852 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49235448 |
| 31 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.48451543 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47827307 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43709900 |
| 34 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41685184 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40956858 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38901353 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38799103 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38126187 |
| 39 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36858535 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35957251 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35599828 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34678840 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32227703 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31462994 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30514464 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29694941 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29031657 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28626766 |
| 49 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28306265 |
| 50 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27902605 |
| 51 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27576803 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27575514 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24850412 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24469081 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22342813 |
| 56 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22272391 |
| 57 | AR_19668381_ChIP-Seq_PC3_Human | 1.21096130 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19831255 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19451261 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16304023 |
| 61 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14678547 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14596525 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13810893 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12144579 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10621648 |
| 66 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10089307 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08582273 |
| 68 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08433265 |
| 69 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08433265 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07025742 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05626375 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05457162 |
| 73 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.05311608 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04374563 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04266114 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03830185 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03309966 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02715064 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01557106 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01468034 |
| 81 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01456439 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00750620 |
| 83 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00606031 |
| 84 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00364415 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99334653 |
| 86 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99162237 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98825575 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97626825 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95609031 |
| 90 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94898533 |
| 91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94545381 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94402562 |
| 93 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94286167 |
| 94 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93963528 |
| 95 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93627720 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93151813 |
| 97 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93132879 |
| 98 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92525363 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90812386 |
| 100 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90533993 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90374032 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89142875 |
| 103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88492843 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88031111 |
| 105 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87555550 |
| 106 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.86767727 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86082490 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86018420 |
| 109 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85776593 |
| 110 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.85652993 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85596021 |
| 112 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85329995 |
| 113 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84935668 |
| 114 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84113223 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83034817 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82946681 |
| 117 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82805316 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82525595 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82251656 |
| 120 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82203799 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82014427 |
| 122 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80596863 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.78115142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.69354545 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.62479814 |
| 3 | MP0000751_myopathy | 3.87195018 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.34609238 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.30670615 |
| 6 | MP0003646_muscle_fatigue | 3.27286442 |
| 7 | MP0003880_abnormal_central_pattern | 3.17012200 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.05464629 |
| 9 | MP0002822_catalepsy | 2.90187710 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.59839798 |
| 11 | MP0004270_analgesia | 2.50890116 |
| 12 | * MP0009745_abnormal_behavioral_response | 2.41275350 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.33709090 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.30758794 |
| 15 | MP0009046_muscle_twitch | 2.29257541 |
| 16 | * MP0002064_seizures | 2.20672035 |
| 17 | MP0005330_cardiomyopathy | 2.16380200 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.08435806 |
| 19 | MP0000749_muscle_degeneration | 2.06491082 |
| 20 | MP0005670_abnormal_white_adipose | 2.03824721 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.01246782 |
| 22 | MP0004085_abnormal_heartbeat | 1.96019173 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.92753112 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.92158062 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 1.91749821 |
| 26 | MP0002272_abnormal_nervous_system | 1.91600630 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.81841712 |
| 28 | MP0001486_abnormal_startle_reflex | 1.81667519 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.78271236 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.77695961 |
| 31 | MP0004484_altered_response_of | 1.77608952 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.76882523 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.76566760 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.73358176 |
| 35 | MP0004130_abnormal_muscle_cell | 1.59425721 |
| 36 | MP0008569_lethality_at_weaning | 1.58661665 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.53974958 |
| 38 | MP0004924_abnormal_behavior | 1.53397004 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.53397004 |
| 40 | MP0004233_abnormal_muscle_weight | 1.51894845 |
| 41 | MP0006138_congestive_heart_failure | 1.45388961 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.44801332 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.43641374 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.43143856 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.43143856 |
| 46 | MP0004510_myositis | 1.41419362 |
| 47 | MP0000747_muscle_weakness | 1.38535190 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.38344995 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.36932566 |
| 50 | MP0001970_abnormal_pain_threshold | 1.36401194 |
| 51 | MP0002269_muscular_atrophy | 1.32507905 |
| 52 | MP0003329_amyloid_beta_deposits | 1.30839571 |
| 53 | MP0004858_abnormal_nervous_system | 1.30810427 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.29246837 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.28383696 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.27869560 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.27182405 |
| 58 | MP0002736_abnormal_nociception_after | 1.26797965 |
| 59 | MP0005165_increased_susceptibility_to | 1.25890599 |
| 60 | MP0002184_abnormal_innervation | 1.25753953 |
| 61 | MP0005369_muscle_phenotype | 1.22981498 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.19605961 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.19228904 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.18984490 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.18146469 |
| 66 | MP0000778_abnormal_nervous_system | 1.17954012 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.13880504 |
| 68 | MP0003283_abnormal_digestive_organ | 1.12248005 |
| 69 | MP0003879_abnormal_hair_cell | 1.11408697 |
| 70 | MP0001529_abnormal_vocalization | 1.11380212 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.07585764 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.07307943 |
| 73 | MP0000955_abnormal_spinal_cord | 1.07100905 |
| 74 | MP0003279_aneurysm | 1.06742591 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.02767756 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.02747235 |
| 77 | MP0003633_abnormal_nervous_system | 1.00322297 |
| 78 | * MP0002882_abnormal_neuron_morphology | 1.00085940 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.97752715 |
| 80 | MP0000579_abnormal_nail_morphology | 0.93806225 |
| 81 | MP0005409_darkened_coat_color | 0.92202901 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.91198763 |
| 83 | MP0001984_abnormal_olfaction | 0.89267723 |
| 84 | MP0003122_maternal_imprinting | 0.87610104 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 0.86945358 |
| 86 | MP0004142_abnormal_muscle_tone | 0.86772387 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.82742214 |
| 88 | MP0004885_abnormal_endolymph | 0.82045572 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.81557962 |
| 90 | MP0005535_abnormal_body_temperature | 0.80531765 |
| 91 | MP0000266_abnormal_heart_morphology | 0.80054002 |
| 92 | MP0004043_abnormal_pH_regulation | 0.78579112 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.77947692 |
| 94 | MP0003631_nervous_system_phenotype | 0.76891483 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76869339 |
| 96 | MP0001905_abnormal_dopamine_level | 0.76400681 |
| 97 | MP0002152_abnormal_brain_morphology | 0.75578475 |
| 98 | MP0005187_abnormal_penis_morphology | 0.74177015 |
| 99 | MP0008874_decreased_physiological_sensi | 0.74146488 |
| 100 | MP0002229_neurodegeneration | 0.71811534 |
| 101 | MP0005503_abnormal_tendon_morphology | 0.69936468 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.69688188 |
| 103 | MP0008004_abnormal_stomach_pH | 0.68429800 |
| 104 | MP0003828_pulmonary_edema | 0.67558612 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.66717225 |
| 106 | * MP0005551_abnormal_eye_electrophysiolog | 0.66093716 |
| 107 | MP0001958_emphysema | 0.65795968 |
| 108 | MP0004272_abnormal_basement_membrane | 0.64790385 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.64108983 |
| 110 | MP0000920_abnormal_myelination | 0.63821334 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.62624985 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.62412368 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.62333053 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.62299987 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.62211787 |
| 116 | MP0002108_abnormal_muscle_morphology | 0.62028619 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.61687852 |
| 118 | * MP0003634_abnormal_glial_cell | 0.60348229 |
| 119 | MP0000343_altered_response_to | 0.54651648 |
| 120 | MP0002128_abnormal_blood_circulation | 0.53042273 |
| 121 | MP0003690_abnormal_glial_cell | 0.52262752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.22529554 |
| 2 | Atrial fibrillation (HP:0005110) | 4.88259262 |
| 3 | Focal motor seizures (HP:0011153) | 4.74247211 |
| 4 | Myokymia (HP:0002411) | 4.70002016 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 4.68204182 |
| 6 | Supraventricular tachycardia (HP:0004755) | 4.47001668 |
| 7 | Bundle branch block (HP:0011710) | 4.44746946 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.39366900 |
| 9 | Supraventricular arrhythmia (HP:0005115) | 4.37067937 |
| 10 | Prolonged QT interval (HP:0001657) | 4.34040640 |
| 11 | Ventricular fibrillation (HP:0001663) | 4.30976483 |
| 12 | Syncope (HP:0001279) | 4.28479685 |
| 13 | Ventricular tachycardia (HP:0004756) | 4.11873948 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.05246705 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.01384947 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 3.90785940 |
| 17 | Focal seizures (HP:0007359) | 3.79367602 |
| 18 | Visual hallucinations (HP:0002367) | 3.73658465 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.60128106 |
| 20 | Abnormal EKG (HP:0003115) | 3.56428442 |
| 21 | Ventricular arrhythmia (HP:0004308) | 3.43305253 |
| 22 | Heart block (HP:0012722) | 3.41136943 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.32683795 |
| 24 | Muscle fiber splitting (HP:0003555) | 3.24714078 |
| 25 | Atrioventricular block (HP:0001678) | 3.21755000 |
| 26 | Abnormal atrioventricular conduction (HP:0005150) | 3.15951326 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 3.12479340 |
| 28 | Lipoatrophy (HP:0100578) | 3.03930060 |
| 29 | Myotonia (HP:0002486) | 2.98033038 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.95316899 |
| 31 | Subaortic stenosis (HP:0001682) | 2.95316899 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 2.94756026 |
| 33 | Dysmetric saccades (HP:0000641) | 2.87239400 |
| 34 | EMG: myopathic abnormalities (HP:0003458) | 2.83645310 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.83034216 |
| 36 | Palpitations (HP:0001962) | 2.81390893 |
| 37 | Difficulty running (HP:0009046) | 2.78095917 |
| 38 | Pheochromocytoma (HP:0002666) | 2.69304979 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.68475762 |
| 40 | Depression (HP:0000716) | 2.62689833 |
| 41 | Poor eye contact (HP:0000817) | 2.62654556 |
| 42 | Myoglobinuria (HP:0002913) | 2.60700509 |
| 43 | Action tremor (HP:0002345) | 2.57159932 |
| 44 | Febrile seizures (HP:0002373) | 2.56539432 |
| 45 | Dilated cardiomyopathy (HP:0001644) | 2.55668257 |
| 46 | Lower limb amyotrophy (HP:0007210) | 2.55247671 |
| 47 | Generalized tonic-clonic seizures (HP:0002069) | 2.53611188 |
| 48 | Dysdiadochokinesis (HP:0002075) | 2.52915946 |
| 49 | Anxiety (HP:0000739) | 2.51363583 |
| 50 | Left ventricular hypertrophy (HP:0001712) | 2.50834186 |
| 51 | Atonic seizures (HP:0010819) | 2.50113544 |
| 52 | Impaired social interactions (HP:0000735) | 2.49891346 |
| 53 | Abnormal social behavior (HP:0012433) | 2.49891346 |
| 54 | Absence seizures (HP:0002121) | 2.47955964 |
| 55 | Ankle clonus (HP:0011448) | 2.47238133 |
| 56 | Broad-based gait (HP:0002136) | 2.42094981 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.38776837 |
| 58 | Central scotoma (HP:0000603) | 2.34933831 |
| 59 | Ragged-red muscle fibers (HP:0003200) | 2.33055900 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 2.33044713 |
| 61 | Hypoplastic left heart (HP:0004383) | 2.32543575 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.30264697 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.27472818 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27410592 |
| 65 | Postural instability (HP:0002172) | 2.27238834 |
| 66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.26815450 |
| 67 | Palmoplantar keratoderma (HP:0000982) | 2.26570985 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25750348 |
| 69 | Dialeptic seizures (HP:0011146) | 2.22876052 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.17933291 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14409112 |
| 72 | Scapular winging (HP:0003691) | 2.12961935 |
| 73 | Gaze-evoked nystagmus (HP:0000640) | 2.12608255 |
| 74 | Congenital malformation of the right heart (HP:0011723) | 2.12488166 |
| 75 | Double outlet right ventricle (HP:0001719) | 2.12488166 |
| 76 | Dysmetria (HP:0001310) | 2.12114922 |
| 77 | Neck muscle weakness (HP:0000467) | 2.11042932 |
| 78 | Rapidly progressive (HP:0003678) | 2.10934908 |
| 79 | Urinary urgency (HP:0000012) | 2.08126299 |
| 80 | Difficulty climbing stairs (HP:0003551) | 2.07943522 |
| 81 | Frequent falls (HP:0002359) | 2.04296156 |
| 82 | Genetic anticipation (HP:0003743) | 2.04119990 |
| 83 | Increased connective tissue (HP:0009025) | 2.02707287 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 1.99942384 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94213130 |
| 86 | Truncal ataxia (HP:0002078) | 1.92563662 |
| 87 | Limb-girdle muscle atrophy (HP:0003797) | 1.90655876 |
| 88 | Abnormality of the tricuspid valve (HP:0001702) | 1.89853396 |
| 89 | Hemiplegia (HP:0002301) | 1.88338821 |
| 90 | Bradycardia (HP:0001662) | 1.88124426 |
| 91 | Testicular atrophy (HP:0000029) | 1.86139830 |
| 92 | Athetosis (HP:0002305) | 1.85633957 |
| 93 | Steppage gait (HP:0003376) | 1.85426608 |
| 94 | Torticollis (HP:0000473) | 1.85343804 |
| 95 | Resting tremor (HP:0002322) | 1.82379757 |
| 96 | Abnormality of the foot musculature (HP:0001436) | 1.81078017 |
| 97 | Hypoplastic heart (HP:0001961) | 1.80750976 |
| 98 | Abnormality of the lower motor neuron (HP:0002366) | 1.79449423 |
| 99 | Congestive heart failure (HP:0001635) | 1.76869148 |
| 100 | Obstructive sleep apnea (HP:0002870) | 1.76468886 |
| 101 | Progressive inability to walk (HP:0002505) | 1.76299237 |
| 102 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76145668 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.76032912 |
| 104 | Papilledema (HP:0001085) | 1.75842149 |
| 105 | Lower limb muscle weakness (HP:0007340) | 1.73241858 |
| 106 | Lymphangioma (HP:0100764) | 1.73034987 |
| 107 | Ketoacidosis (HP:0001993) | 1.72730173 |
| 108 | Hemiparesis (HP:0001269) | 1.72192795 |
| 109 | Mutism (HP:0002300) | 1.72045055 |
| 110 | Hamartoma of the eye (HP:0010568) | 1.72039264 |
| 111 | Amblyopia (HP:0000646) | 1.70953102 |
| 112 | Abnormal eating behavior (HP:0100738) | 1.70615780 |
| 113 | Anomalous pulmonary venous return (HP:0010772) | 1.68225537 |
| 114 | Skin nodule (HP:0200036) | 1.67595241 |
| 115 | Insidious onset (HP:0003587) | 1.65121727 |
| 116 | Termporal pattern (HP:0011008) | 1.65121727 |
| 117 | Scanning speech (HP:0002168) | 1.64864819 |
| 118 | Areflexia of lower limbs (HP:0002522) | 1.64463502 |
| 119 | Sudden cardiac death (HP:0001645) | 1.63855344 |
| 120 | EMG: neuropathic changes (HP:0003445) | 1.63223486 |
| 121 | Pointed chin (HP:0000307) | 1.60678620 |
| 122 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.58779901 |
| 123 | Rimmed vacuoles (HP:0003805) | 1.57753124 |
| 124 | Abnormality of the salivary glands (HP:0010286) | 1.57598045 |
| 125 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.55302148 |
| 126 | Transposition of the great arteries (HP:0001669) | 1.55302148 |
| 127 | Abnormal connection of the cardiac segments (HP:0011545) | 1.55302148 |
| 128 | Aneurysm (HP:0002617) | 1.54924850 |
| 129 | Generalized muscle weakness (HP:0003324) | 1.50387825 |
| 130 | Preauricular pit (HP:0004467) | 1.49535949 |
| 131 | Periauricular skin pits (HP:0100277) | 1.49535949 |
| 132 | Cerebral aneurysm (HP:0004944) | 1.48785242 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.47902829 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.47902829 |
| 135 | Slow progression (HP:0003677) | 1.45523146 |
| 136 | Turricephaly (HP:0000262) | 1.43589232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.58468028 |
| 2 | NTRK3 | 3.23154920 |
| 3 | PHKG2 | 2.88602744 |
| 4 | PHKG1 | 2.88602744 |
| 5 | MAP3K9 | 2.83405002 |
| 6 | LMTK2 | 2.74356085 |
| 7 | MARK1 | 2.72892729 |
| 8 | MAP3K4 | 2.41252349 |
| 9 | TTN | 2.32559152 |
| 10 | DAPK2 | 2.09388428 |
| 11 | PAK6 | 2.05355223 |
| 12 | PRKD3 | 2.01127941 |
| 13 | MINK1 | 1.99220159 |
| 14 | DMPK | 1.91429063 |
| 15 | NTRK2 | 1.84459830 |
| 16 | CAMKK1 | 1.66478193 |
| 17 | STK38 | 1.64231197 |
| 18 | PINK1 | 1.62944191 |
| 19 | MYLK | 1.60214355 |
| 20 | KSR2 | 1.59890198 |
| 21 | NTRK1 | 1.58742980 |
| 22 | MAP2K7 | 1.53474161 |
| 23 | PAK3 | 1.51237406 |
| 24 | PDK4 | 1.51159954 |
| 25 | PDK3 | 1.51159954 |
| 26 | TRIB3 | 1.43625185 |
| 27 | OBSCN | 1.37283727 |
| 28 | MAP2K4 | 1.36663065 |
| 29 | NEK1 | 1.32651710 |
| 30 | MUSK | 1.32407822 |
| 31 | CDK5 | 1.28218391 |
| 32 | RIPK1 | 1.23342816 |
| 33 | KSR1 | 1.19848029 |
| 34 | MAP3K5 | 1.16715251 |
| 35 | TAOK1 | 1.15683242 |
| 36 | CDC42BPA | 1.14113436 |
| 37 | UHMK1 | 1.11495873 |
| 38 | MAP3K6 | 1.11473538 |
| 39 | PKN2 | 1.11056081 |
| 40 | CAMK2D | 1.09839402 |
| 41 | TNIK | 1.08232728 |
| 42 | CAMK2A | 1.07653362 |
| 43 | CAMK1 | 1.07616756 |
| 44 | LIMK1 | 1.05254057 |
| 45 | TYRO3 | 1.03096721 |
| 46 | SIK2 | 1.02175366 |
| 47 | LATS2 | 0.98705329 |
| 48 | PRKCH | 0.97225484 |
| 49 | GRK5 | 0.96687540 |
| 50 | STK11 | 0.90489884 |
| 51 | CAMKK2 | 0.89761007 |
| 52 | MAPK13 | 0.86201901 |
| 53 | WNK1 | 0.85649307 |
| 54 | PRKD1 | 0.85474940 |
| 55 | RET | 0.84768306 |
| 56 | DAPK1 | 0.83045801 |
| 57 | PRKCG | 0.82602476 |
| 58 | EPHA3 | 0.82239804 |
| 59 | PIK3CA | 0.81946474 |
| 60 | CAMK4 | 0.81725556 |
| 61 | EPHB1 | 0.81483128 |
| 62 | GRK7 | 0.81187263 |
| 63 | CAMK1G | 0.79797986 |
| 64 | ROCK1 | 0.78483590 |
| 65 | DAPK3 | 0.78399597 |
| 66 | PNCK | 0.78277084 |
| 67 | MARK2 | 0.75908380 |
| 68 | MAPKAPK3 | 0.74995682 |
| 69 | PDGFRA | 0.74617668 |
| 70 | WNK4 | 0.74545581 |
| 71 | FES | 0.74249775 |
| 72 | MAP3K7 | 0.73759774 |
| 73 | PRPF4B | 0.71659304 |
| 74 | TIE1 | 0.71268998 |
| 75 | PLK2 | 0.71036452 |
| 76 | SGK494 | 0.70872931 |
| 77 | SGK223 | 0.70872931 |
| 78 | PKN1 | 0.69728019 |
| 79 | PTK2B | 0.68494372 |
| 80 | ALK | 0.68409393 |
| 81 | RIPK4 | 0.68361644 |
| 82 | PDK2 | 0.67431805 |
| 83 | SGK1 | 0.66924232 |
| 84 | PDPK1 | 0.66593663 |
| 85 | MAP3K12 | 0.66042935 |
| 86 | SGK3 | 0.65828301 |
| 87 | ROCK2 | 0.64954213 |
| 88 | MAP3K2 | 0.63087637 |
| 89 | MAPK12 | 0.62486637 |
| 90 | EPHB2 | 0.62119881 |
| 91 | RPS6KL1 | 0.60950891 |
| 92 | RPS6KC1 | 0.60950891 |
| 93 | ICK | 0.59480601 |
| 94 | CAMK2B | 0.59163635 |
| 95 | PDK1 | 0.57448321 |
| 96 | SGK2 | 0.57257763 |
| 97 | MAPK4 | 0.56449266 |
| 98 | FER | 0.55462967 |
| 99 | CDK15 | 0.55086594 |
| 100 | CDK18 | 0.54537846 |
| 101 | RPS6KA3 | 0.54397761 |
| 102 | MAP3K1 | 0.54059715 |
| 103 | TRPM7 | 0.53301773 |
| 104 | TESK1 | 0.53122233 |
| 105 | CASK | 0.51547116 |
| 106 | PRKAA1 | 0.51291211 |
| 107 | CAMK2G | 0.51214368 |
| 108 | MAPK10 | 0.51210076 |
| 109 | CDK14 | 0.50395893 |
| 110 | ERBB2 | 0.50183709 |
| 111 | RPS6KA6 | 0.49198977 |
| 112 | PTK2 | 0.49085521 |
| 113 | PRKACG | 0.48540994 |
| 114 | ARAF | 0.48350269 |
| 115 | NEK9 | 0.47829095 |
| 116 | DDR2 | 0.45918248 |
| 117 | * PRKCE | 0.45460079 |
| 118 | CDK11A | 0.45243546 |
| 119 | PRKG1 | 0.44962803 |
| 120 | STK4 | 0.44631261 |
| 121 | RPS6KA2 | 0.44452206 |
| 122 | PRKACA | 0.43445791 |
| 123 | DYRK1A | 0.42358737 |
| 124 | MAPK7 | 0.42167475 |
| 125 | PRKAA2 | 0.40923497 |
| 126 | PRKG2 | 0.37869734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.69791097 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.64975095 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.40462699 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.37882907 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35586912 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.29236763 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28936832 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.23426477 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.20062177 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.10945981 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10411056 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02293594 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.98917998 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.96540155 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92584064 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91714397 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.89468380 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81065954 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.73989385 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73083679 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72890249 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71519154 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.64236286 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63823379 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60210385 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.57548293 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53513003 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50706341 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.49555294 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46461963 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36867833 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35152809 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31720262 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30371195 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29792269 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.25597733 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25200340 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20686347 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19769430 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18435956 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.14070846 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05927885 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03098725 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99978277 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95113047 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94422856 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.91065465 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89134926 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.87871262 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87375938 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85987689 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84528764 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.83633143 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83126615 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79992116 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79748971 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79745040 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79363924 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74494032 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74373002 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73647486 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72111171 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71059622 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70851346 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70182635 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69589726 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69144180 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.67117298 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65130353 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62930873 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58896092 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58525090 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57869916 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.57457947 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56777767 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55888260 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54489209 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54032795 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53881359 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.53814930 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52936892 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52815535 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51959133 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51678566 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51044001 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50928786 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.50598300 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48703712 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47950698 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47905989 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47866565 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47661961 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47461571 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47114771 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.45581536 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45450320 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.44876736 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44793959 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.42367944 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42128081 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41789859 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41390337 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.37592146 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37528138 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37448305 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37147685 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36482269 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36061339 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35560290 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35111235 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32100171 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28742705 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28676401 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.28079704 |

